ICD-10 Code B44.2 | Tonsillar aspergillosis Symptoms, Diagnosis, Billing

Tonsillar aspergillosis is a rare fungal infection of the tonsils caused by the Aspergillus species. It is clinically significant due to its potential to cause severe throat pain, dysphagia, and systemic symptoms in immunocompromised patients. Accurate coding with ICD-10 Code B44.2 facilitates proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B44.2 for Tonsillar aspergillosis?

ICD-10 Code B44.2 specifically represents Tonsillar aspergillosis, a localized infection of the tonsils caused by the Aspergillus fungus. This code should be used in clinical documentation and billing when a patient presents with symptoms indicative of this condition, particularly in cases involving immunocompromised individuals or those with underlying respiratory diseases.

ICD-10 Code B44.2 – Clinical Definition and Explanation of Tonsillar aspergillosis

Tonsillar aspergillosis is primarily caused by inhalation or ingestion of Aspergillus spores, leading to localized infection in the tonsils. The condition can progress rapidly, especially in immunocompromised patients, necessitating prompt medical attention to prevent complications such as systemic infection.

Key Clinical Features:

• Severe sore throat and dysphagia.
• Fever and systemic symptoms in advanced cases.
• Presence of necrotic tonsillar tissue upon examination.
• Potential for airway obstruction in severe cases.

ICD-10 Code B44.2 for Tonsillar aspergillosis – SOAP Notes & Clinical Use

ICD-10 Code B44.2 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plan for Tonsillar aspergillosis. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate billing.

What Does ICD-10 Code B44.2 for Tonsillar aspergillosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B44.2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Tonsillar aspergillosis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B44.2 – Tonsillar aspergillosis

Tonsillar aspergillosis may require hospitalization, especially in severe cases. Treatment typically involves antifungal therapy and supportive care to manage symptoms.

Antibiotic Therapy:

• First-line: Voriconazole or Amphotericin B, typically for 2-6 weeks depending on severity.
• Alternative: Posaconazole for patients intolerant to first-line agents.
• Consideration of adjunctive therapies based on clinical response.

Supportive Care:

• Hydration and analgesics for pain management.
• Corticosteroids may be indicated to reduce inflammation.
• Monitoring for potential airway obstruction.

Infection Control:

• Implement standard precautions to prevent spread.
• Isolation may be necessary for immunocompromised patients.
• Education on hygiene practices for patients and caregivers.

How to Document Symptoms of Tonsillar aspergillosis (ICD-10 B44.2) in SOAP Notes

Subjective:

• Patient reports severe sore throat and difficulty swallowing.
• History of recent respiratory illness or immunocompromised status.
• Complaints of fever and malaise.

Objective:

• Physical examination reveals swollen, necrotic tonsils.
• Fever of 101°F noted.
• Throat culture shows growth of Aspergillus species.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Tonsillar aspergillosis (ICD-10 Code B44.2)

Assessment:

• Diagnosis: Tonsillar aspergillosis, moderate severity.
• ICD-10 Code: B44.2.
• Contributing factors: Immunocompromised status, recent respiratory infection.

Plan:

• Initiate antifungal therapy with Voriconazole.
• Provide education on symptom management and follow-up care.
• Schedule follow-up appointment in one week to assess treatment response.

Treatment & Plan Section for ICD-10 Code B44.2 – Tonsillar aspergillosis

• First-line pharmacologic treatment includes Voriconazole or Amphotericin B.
• Non-pharmacologic strategies include hydration and pain management.
• Monitoring for treatment efficacy and potential side effects.
• Follow-up appointments to reassess clinical status and adjust treatment as necessary.

Using ICD-10 Code B44.2 for Tonsillar aspergillosis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections clearly reflect symptoms and examination findings.
• Align treatment plans with clinical guidelines to support justified billing.
• Document all relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Tonsillar aspergillosis

• B44.0 – Aspergillosis, unspecified
• B44.1 – Pulmonary aspergillosis

ICD-10 Code B44.2 in Medical Billing and Insurance for Tonsillar aspergillosis

ICD-10 Code B44.2 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of this code.
• Use in conjunction with appropriate CPT codes for antifungal therapy and consultations.
• Ensure that the patient's immunocompromised status is clearly noted in the documentation.

Common CPT Pairings: